Vanberra Signal

Olio Labs

Curated by Signal

AI-based drug development platform for combinational therapies

Overview

AI-based drug development platform for combinational therapies. It focuses on designing drug combinations by considering the thousands of interacting proteins in the body rather than just targeting one or two.

Key facts

Founded
2023
Headquarters
United States

Business model

Contact

Open roles

3 roles
  • Senior Technician

    San Francisco Bay Area · On-site · Volunteer

  • Part-Time In-Vivo Research Technician

    San Francisco Bay Area · On-site · Volunteer

  • Part-Time In-Vivo Research Technician

    San Francisco Bay Area · On-site · Volunteer

More on Vanberra Signal

Members only

Competitors & similar companies

More Health Technology companies
  • Provider of an AI-based drug designing and modeling tool for researchers and scientists

    Health TechnologySanta Rosa, United States
  • Provider of an online platform for assisting regulatory requirements

    Health TechnologyNew Orleans, United States
  • AI powered smart glasses designed to the daily lives of individuals with visual impairments

    Health TechnologyHouston, United States

About Olio Labs

What does Olio Labs do?

AI-based drug development platform for combinational therapies.

Where is Olio Labs headquartered?

Olio Labs is headquartered in United States.

When was Olio Labs founded?

Olio Labs was founded in 2023.

Which sector is Olio Labs in?

Olio Labs operates in Health Technology.

Who are Olio Labs's competitors?

Companies similar to Olio Labs include BioPharmics, Clearview360, and ApolloVision.

Is Olio Labs hiring?

Yes. Olio Labs has 3 open roles listed on Vanberra Signal.